Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients
- PMID: 12843166
- DOI: 10.1210/jc.2002-022013
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients
Abstract
Critical illness is often associated with reduced TSH and thyroid hormone secretion as well as marked changes in peripheral thyroid hormone metabolism, resulting in low serum T(3) and high rT(3) levels. To study the mechanism(s) of the latter changes, we determined serum thyroid hormone levels and the expression of the type 1, 2, and 3 iodothyronine deiodinases (D1, D2, and D3) in liver and skeletal muscle from deceased intensive care patients. To study mechanisms underlying these changes, 65 blood samples, 65 liver, and 66 skeletal muscle biopsies were obtained within minutes after death from 80 intensive care unit patients randomized for intensive or conventional insulin treatment. Serum thyroid parameters and the expression of tissue D1-D3 were determined. Serum TSH, T(4), T(3), and the T(3)/rT(3) ratio were lower, whereas serum rT(3) was higher than in normal subjects (P < 0.0001). Liver D1 activity was down-regulated and D3 activity was induced in liver and skeletal muscle. Serum T(3)/rT(3) ratio correlated positively with liver D1 activity (P < 0.001) and negatively with liver D3 activity (ns). These parameters were independent of the type of insulin treatment. Liver D1 and serum T(3)/rT(3) were highest in patients who died from severe brain damage, intermediate in those who died from sepsis or excessive inflammation, and lowest in patients who died from cardiovascular collapse (P < 0.01). Liver D3 showed an opposite relationship. Acute renal failure requiring dialysis and need of inotropes were associated with low liver D1 activity (P < 0.01 and P = 0.06) and high liver D3 (P < 0.01) and skeletal muscle D3 (P < 0.05) activity. Liver D1 activity was negatively correlated with plasma urea (P = 0.002), creatinine (P = 0.06), and bilirubin (P < 0.0001). D1 and D3 mRNA levels corresponded with enzyme activities (both P < 0.001), suggesting regulation of the expression of both deiodinases at the pretranslational level. This is the first study relating tissue deiodinase activities with serum thyroid hormone levels and clinical parameters in a large group of critically ill patients. Liver D1 is down-regulated and D3 (which is not present in liver and skeletal muscle of healthy individuals) is induced, particularly in disease states associated with poor tissue perfusion. These observed changes, in correlation with a low T(3)/rT(3) ratio, may represent tissue-specific ways to reduce thyroid hormone bioactivity during cellular hypoxia and contribute to the low T(3) syndrome of severe illness.
Similar articles
-
Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities.J Clin Endocrinol Metab. 2005 Aug;90(8):4559-65. doi: 10.1210/jc.2005-0535. Epub 2005 May 10. J Clin Endocrinol Metab. 2005. PMID: 15886232 Clinical Trial.
-
Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity.J Clin Endocrinol Metab. 2005 Dec;90(12):6460-5. doi: 10.1210/jc.2005-0866. Epub 2005 Sep 27. J Clin Endocrinol Metab. 2005. PMID: 16189257
-
Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2.Endocrinology. 2005 Dec;146(12):5604-11. doi: 10.1210/en.2005-0963. Epub 2005 Sep 8. Endocrinology. 2005. PMID: 16150898
-
Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease.J Endocrinol. 2011 Jun;209(3):283-97. doi: 10.1530/JOE-10-0481. Epub 2011 Mar 17. J Endocrinol. 2011. PMID: 21415143 Review.
-
Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation.J Endocrinol. 2011 Jun;209(3):273-82. doi: 10.1530/JOE-11-0002. Epub 2011 Mar 11. J Endocrinol. 2011. PMID: 21398344 Review.
Cited by
-
Prognostic Value of Thyroid Hormone FT3 in General Patients Admitted to the Intensive Care Unit.Biomed Res Int. 2020 Jul 12;2020:6329548. doi: 10.1155/2020/6329548. eCollection 2020. Biomed Res Int. 2020. PMID: 32766311 Free PMC article.
-
Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases.Medicine (Baltimore). 2016 Apr;95(14):e3346. doi: 10.1097/MD.0000000000003346. Medicine (Baltimore). 2016. PMID: 27057916 Free PMC article.
-
An extensive review on phenolic compounds and their potential estrogenic properties on skin physiology.Front Cell Dev Biol. 2024 Jan 4;11:1305835. doi: 10.3389/fcell.2023.1305835. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38250328 Free PMC article. Review.
-
Deiodinases: implications of the local control of thyroid hormone action.J Clin Invest. 2006 Oct;116(10):2571-9. doi: 10.1172/JCI29812. J Clin Invest. 2006. PMID: 17016550 Free PMC article. Review.
-
The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-Analysis.Sci Rep. 2018 Sep 20;8(1):14137. doi: 10.1038/s41598-018-32543-7. Sci Rep. 2018. PMID: 30237537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous